Answers are grounded in this paper and cite their sources.
Case report shows elevated T effector memory cells associate with disease recurrence in oral squamous cell carcinoma, suggesting risk factor implications.
Description Nearly half of oral squamous cell carcinoma (OSCC) patients experience disease recurrence within one year of treatment, with few predictive risk factors. There is a vital need to identify factors mediating early OSCC recurrence. Here we present two patients which exemplify these disparate outcomes and contrast known oral cancer risk factors. A 53-year-old never-smoker with no known risk factors was diagnosed with aggressive stage 4 OSCC. One year after treatment, he was hospitalized with a femur fracture secondary to extensive metastatic disease, after which he had a rapidly fulminant decline and died. In contrast, an 86-year-old with significant smoking history was diagnosed with similar stage 4 OSCC; two years after treatment she has no evidence of recurrence. Given known risk factors, our older patient with significant tobacco exposure was expected to have worse outcomes than a young, otherwise healthy patient. Instead, we found a negative association between disease outcomes and circulating proportion of highly differentiated T effector memory (HD TEMRA) cells; elevated levels of CD8+ HD TEMRA cells is significantly associated with poor disease control. While both patients had similar diseases and treatments, our 53-year-old patient had 42.8% CD8+ HD TEMRA cells vs 0.23% in our 86-year-old patient. We posit an immunologically aged phenotype, particularly a high HD TEMRA cell proportion, raises OSCC recurrence risk due to poor minimal residual disease control after surgery.
No takes yet. Share an insight, caveat, or question.
Brammer et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: